Synthetic Biology Patent Applications Expected to Present New Challenges
June 6, 2008
Foley Partner Mark Waxman and Patent Agent Vid Mohan-Ram recently authored an article titled, “Synthetic Biology Patent Applications Expected to Present New Challenges,” in the June 6, 2008 issue of Life Sciences Law & Industry Report. The article addresses the U.S. patent applications that expressly focus on synthetic biology, and how the U.S. Patent & Trademark Office is handling and examining them.
Reproduced with permission from Life Sciences Law & Industry Report, Vol. 2, No. 12 (June 6, 2008) pp. 473-474. Copyright 2008 by The Bureau of National Affairs, Inc. (800-372-1033) http://www.bna.com.
Related Insights
July 17, 2025
Health Care Law Today
One Big Beautiful Bill: Slashed Budgets Will Disrupt the Medicaid Program
The new federal budget law, the One Big Beautiful Bill Act (the Act), enacted on July 4, 2025, makes dramatic changes to the Medicaid…
July 16, 2025
Foley Viewpoints
Changes to the College and University Endowment Tax
The One Big Beautiful Bill Act (OBBBA) modifies the excise tax on net investment income of private colleges and universities under…
July 16, 2025
Health Care Law Today Podcast
Episode 36: Let’s Talk Compliance: The Risks and Pitfalls of Health Care Supply Chain Compliance
In this episode, Monica Chmielewski, vice chair of Foley’s Health Care Practice Group and Shannon Sumner, Chief Compliance Officer and Nashville’s Office Managing Principal of PYA explore how supply chain compliance is affecting the health care industry and share the risks and penalties associated with not being in compliance.